EUVIMEDEUVIMED entdecken
Crossref

Recreational cannabis and opioid distribution

Shyam Raman iD, Johanna Catherine Maclean iD, W David Bradford iD, Coleman Drake iD

Health Economics · 2023

DOI: 10.1002/hec.4652 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Health Economics, 2023. Verfasst von Shyam Raman und 3 weiteren Autor:innen. Beteiligte Einrichtung: Jeb E. Brooks School of Public Policy, Cornell University, Ithaca, New York, USA. Hauptthemen laut MEDLINE: Analgesics, Opioid, Cannabis. Die Arbeit wurde bisher 6-mal zitiert (Crossref) und nennt 33 Literaturangaben. Gefördert von: NIDA NIH HHS, National Institute on Drug Abuse.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Twenty‐one U.S. states have passed recreational cannabis laws as of November 2022. Cannabis may be a substitute for prescription opioids in the treatment of chronic pain. Previous studies have assessed recreational cannabis laws' effects on opioid prescriptions financed by specific private or public payers or dispensed to a unique endpoint. Our study adds to the literature in three important ways: by (1) examining these laws' impacts on prescription opioid dispensing across all payers and endpoints, (2) adjusting for important opioid‐related policies such as opioid prescribing limits, and (3) modeling opioids separately by type. We implement two‐way fixed‐effects regressions and leverage variation from eleven U.S. states that adopted a recreational cannabis law (RCL) between 2010 and 2019. We find that RCLs lead to a reduction in codeine dispensed at retail pharmacies. Among prescription opioids, codeine is particularly likely to be used non‐medically. Thus, the finding that RCLs appear to reduce codeine dispensing is potentially promising from a public health perspective.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Analgesics, OpioidCannabisHumansUnited StatesPractice Patterns, Physicians'Legislation, DrugCodeine

Stichwörter der Autor:innen

cannabiscodeinedifference-in-differencesopioidssubstance use

Substanzen

Analgesics, OpioidCodeine

Autor:innen und Institutionen

  • Jeb E. Brooks School of Public Policy, Cornell University, Ithaca, New York, USA.
  • Schar School of Policy and Government, George Mason University, NBER, IZA, Fairfax, Virginia, USA.
  • School of Public and International Affairs, University of Georgia, Athens, Georgia, USA.
  • Graduate School of Public Health, University of Pittsburgh, Pittsburgh, Pennsylvania, USA.

ORCID-Profile: Shyam Raman, Johanna Catherine Maclean, W David Bradford, Coleman Drake

Förderung

  • NIDA NIH HHS
  • National Institute on Drug Abuse

Zitieren

APA

Raman, S., Maclean, J. C., Bradford, W. D., & Drake, C. (2023). Recreational cannabis and opioid distribution. Health Economics. https://doi.org/10.1002/hec.4652

Vancouver

Raman S, Maclean JC, Bradford WD, Drake C. Recreational cannabis and opioid distribution. Health Economics. 2023. doi:10.1002/hec.4652

BibTeX
@article{Raman2023,
  author = {Raman, Shyam and Maclean, Johanna Catherine and Bradford, W David and Drake, Coleman},
  title = {Recreational cannabis and opioid distribution},
  journal = {Health Economics},
  year = {2023},
  doi = {10.1002/hec.4652}
}
Kostenlos starten →